ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,931.12
-0.22%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cytrx Corp. (MM) (CYTR)

  7. Cytrx Corp. (MM) (CYTR) News

CYTR

Cytrx (CYTR)

Cytrx Corp. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYTR
DateTimeSourceHeadlineSymbolCompany
19/12/201922:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
18/12/201906:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
18/12/201906:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
18/12/201906:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
18/12/201906:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
18/12/201906:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
16/11/201909:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
14/11/201922:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
30/08/201905:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
09/08/201920:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
02/08/201906:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
02/08/201906:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTRCytrx Corp. (MM)
26/06/201923:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
26/06/201920:16Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CYTRCytrx Corp. (MM)
24/06/201923:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CYTRCytrx Corp. (MM)
07/06/201906:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CYTRCytrx Corp. (MM)
31/05/201923:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
31/05/201923:00PR Newswire (US)CytRx Corporation to Commence Trading on OTCQB Venture MarketNASDAQ:CYTRCytrx Corp. (MM)
15/05/201923:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
15/05/201923:00PR Newswire (US)CytRx Corporation Reports First Quarter 2019 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
08/05/201923:00PR Newswire (US)CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain CancerNASDAQ:CYTRCytrx Corp. (MM)
02/05/201923:00PR Newswire (US)CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazyme A/SNASDAQ:CYTRCytrx Corp. (MM)
29/04/201923:00PR Newswire (US)CytRx Corporation Highlights Enrollment Completion in Phase 2/3 Clinical Trial of Sporadic Inclusion Body Myositis Conducted ...NASDAQ:CYTRCytrx Corp. (MM)
30/03/201900:00PR Newswire (US)CytRx Corporation Reports 2018 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
29/03/201921:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CYTRCytrx Corp. (MM)
13/03/201900:00PR Newswire (US)CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To ...NASDAQ:CYTRCytrx Corp. (MM)
14/02/201901:00PR Newswire (US)CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology Targeting Delivery Directly to the TumorNASDAQ:CYTRCytrx Corp. (MM)
12/02/201901:00PR Newswire (US)CytRx Corporation Highlights Majority of Cancer Patients Do Not Have Targetable Genetic Mutations and Are Therefore Candidate...NASDAQ:CYTRCytrx Corp. (MM)
07/02/201901:00PR Newswire (US)CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in Niemann Pick Disease Type C (...NASDAQ:CYTRCytrx Corp. (MM)
15/01/201922:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:CYTR

Your Recent History

TSXV
RXE
HITB
GHOSTUSD
GHOST by McAfee
COIN
PRISMAUST
Prisma Governance Token
LSE
MDL
Medoil
NASDAQ
WFFAJX
Flex Focus Conservative ...
HITB
CRPTUSD
Crypterium
BOV
AMER3
Americanas ON
LSE
68CV
Investec Bnk 25
USOTC
TBVPY
Thai Beverage Public (PK)
CSE
RVV
Revive Therapeutics
AMEX
BHZ
COIN
NPLCUSD
USOTC
TTBXF
Tritax Big Box REIT (PK)
GATE
SANDETH
Sandbox
CSE
LNK
Link Global Technologies
NASDAQ
RILYG
B Riley Financial
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved